Clover Health appoints Terrence Ronan as Interim CFO effective Jan 27, 2024

CLOVER HEALTH INVESTMENTS, CORP. /DE

Ronan will join as Interim SVP of Finance on Jan 2, 2024, then become Interim CFO on Jan 27, 2024 after Scott Leffler's departure.
Ronan is a certified public accountant (inactive) with prior CFO roles at Purdue Pharma L.P. and Atlantic Power Corporation.
Company will pay AP Services, LLC (AlixPartners subsidiary) a monthly fee of $195,000 for Ronan's services as Interim CFO.
No family relationships or material interests in transactions disclosed between Ronan and any director or executive officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Scott J. Leffler

Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Successor: Terrence Ronan
Filed: December 27, 2023, 6:59 PM ET

following Scott J. Leffler’s previously announced departure as Chief Financial Officer.

Appointed (interim)

Terrence Ronan

Interim Chief Financial Officer

CLOV · CLOVER HEALTH INVESTMENTS, CORP. /DE

Effective: 2024-01-27
Filed: December 27, 2023, 6:59 PM ET

On December 22, 2023, the Board of Directors of Clover Health Investments, Corp. (the “Company”) appointed Mr. Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Scott J. Leffler departed as Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: departure
Role: Chief Financial Officer

Exact text from the filing

following Scott J. Leffler’s previously announced departure as Chief Financial Officer.

View on SEC.gov

Executive change SEC 8-K Item 5.02 confidence 0.95

Terrence Ronan was appointed as Interim Chief Financial Officer at CLOVER HEALTH INVESTMENTS, CORP. /DE.

Action: appointed
Role: Interim Chief Financial Officer

Exact text from the filing

On December 22, 2023, the Board of Directors of Clover Health Investments, Corp. (the “Company”) appointed Mr. Terrence Ronan as Interim Chief Financial Officer, including as principal financial officer and principal accounting officer, effective as of January 27, 2024.

View on SEC.gov

CLOVER HEALTH INVESTMENTS, CORP. /DE filing history →

Source: SEC EDGAR

accession 0001801170-23-000126

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.